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Tetanus in a child as a result  
of the vaccination schedule violation  
– a case report
Halyna Pavlyshyn, Ivanna Horishna, Viktoriia Slyva*
A clinical case of generalized tetanus in a preschooler with vaccination schedule noncompliance was analyzed. Clinical signs of 
generalized severe tetanus are presented. Modern approaches to the treatment of such patients, effectiveness and promises of 
 therapy are shown.
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INTRODUCTION
According the World Health Organisation (WHO) data, 
Ukraine was among the top eight countries with the lowest 
level of immunization coverage in children in 2016-2017. 
Countries like Nigeria, Somalia, South Sudan, Equatorial 
Guinea, Central African Republic, Chad and Syria were rep-
resented together with Ukraine in this list with less than 
50% of infants completely immunized against diphtheria, 
tetanus and pertussis (DTP) (Figure 1, 2 and 3) (1, 2). By Au-
gust 2018, only 48.5% of infants were vaccinated against 
tuberculosis, 36.1% against polio, 53.8% against measles, 
35.5% against hepatitis B, and 37.2% against diphtheria and 
tetanus. The immunization coverage in the Ternopil region 
is the lowest one (3).
Therefore, Ukrainian children are susceptible to diseases 
that have been forgotten elsewhere in the developed 
world. Tetanus is one such disease. 
CASE REPORT
There were two cases of generalized tetanus in preschool-
ers in Ternopil region, Ukraine, in 2016-2017. We present 
one of them. A 5-year-old child had several superficial skin 
traumas during the previous month. A forehead trauma 
 occurred four weeks, left knee trauma two weeks, and left 
palm trauma three days prior to hospital admission. At 
 admission, some excoriations were present from the first 
and second trauma, and an inflamed wound on the left 
palm. 
The parents had asked for medical care on the 3rd day fol-
lowing the last trauma. The complaints included impaired 
swallowing, inability to open the mouth, face asymmetry, 
and forced position of the head with neck muscle hyperto-
nia. Because of that, they were referred to an ear-nose-
throat (ENT) specialist, and later to the Intensive Care Unit 
(ICU) of the Ternopil Regional Children’s Clinical Hospital. 
The child had not been immunized because of parental 
 beliefs.
The patient’s general condition was severe at the time of hos-
pitalization because of neurological symptoms that included 
forced position of the head, which was bent back, asymmetry 
of the eye slots, severe trismus, risus sardonicus, and painful 
nuchal rigidity that became more intense during medical 
manipulations. His skin temperature was 37.5 °C, respiratory 
rate 20 per minute, cardiac rate 120 per  minute, blood oxy-
genation 98%. Breath sound was vesicular with stridorous 
phenomena. Cardiac tones were rhythmic, a bit weak. The 
abdomen was sunken with the anterior abdominal wall mus-
cle rigidity and spasms elicited on  palpation. 
Generalized tetanus with a severe course was diagnosed on 
the basis of history and clinical signs.
33
Paediatr Croat. 2019;63:32-7 Pavlyshyn h., horishna i., slyva v. TeTanus in a child as a resulT of The vaccinaTion schedule violaTion – a case rePorT.
The patient was treated according to the Order of the 
Healthcare Ministry of Ukraine No. 198 as of August 5, 1999 
(4). Equine antitetanus serum, 15,000 IU (1,000 IU/kg), was 
injected intravenously during seven hours after hospital ad-
mission. Because of tetanus immunoglobulin shortage, the 
patient also received normal human immunoglobulin intra-
venously, 70 mL (4 mL/kg) for five days (5). Antibacterial 
(metronidazole, ampicillin + sulbactam) and anticonvulsive 
therapy (diazepam) in adequate doses was also prescribed.
However, 10 hours after hospital admission, opisthotonus 
developed together with respiratory failure that needed ar-
tificial ventilatory support.
Thiopental sodium (2 mg/kg), later diprofol (0.3-0.4-0.8 mg/
kg/h) and morphine for anaesthesia and anticonvulsive 
therapy intensification were prescribed due to a series of 
clonic convulsions resistant to diazepam. The repeat, sec-
ond dose of tetanus toxoid of 15,000 IU intravenously and 
tetanus immunoglobulin 2,500 IU intramuscularly were in-
jected on hospital day five because of continuous clonic 
convulsions and temperature (38.5-38.9 °C) resistant to anti-
pyretic medicine. The patient’s condition remained severe 
but stable for the next five days; the frequency of seizures 
decreased, but they relapsed on days 10-11 of treatment 
requiring heroic doses of anticonvulsive therapy and teta-
nus immunoglobulin in a dose of 2,750 IU. Tracheostomy 
was done.
Positive dynamics started on day 14; the number and inten-
sity of seizures decreased, muscular pain decreased, risus 
sardonicus disappeared. The dose and frequency of anticon-
vulsive therapy was decreased. The patient could open his 
mouth more widely, could take more food enterally, defe-
cate and urinate spontaneously. However, his body tem-
perature was subfebrile, there was a large amount of mu-
cous and serous secretions in the airways that needed fre-
quent aspirations. Ventilation was changed to auxiliary 
ventilator support on day 21 of treatment. By day 30, he 
FIgURE 1. WHO and UNICEF estimates of total tetanus global annually reported cases and DPT coverage, 1980-2016 (DTP3 = 3rd dose of DTP vaccine 
according to vaccination schedule that should be administered at 6 months).
Source: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/tetanus/en/
34
Pavlyshyn h., horishna i., slyva v. TeTanus in a child as a resulT of The vaccinaTion schedule violaTion – a case rePorT. Paediatr Croat. 2019;63:32-7
FIgURE 2. WHO and UNICEF estimates of national immunization coverage by DTP3 in 2016 (DTP3 = 3rd dose of DTP vaccine 
according to vaccination schedule that should be administered at 6 months).
Source: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/tetanus/en/
FIgURE 3. WHO and UNICEF estimates of national immunization coverage by DTP3, Ukraine, 2006-2016 (DTP3 = 3rd dose of DTP vaccine according 
to vaccination schedule that should be administered at 6 months).
Source: http://www.who.int/immunization/monitoring_surveillance/data/ukr.pdf.
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could breathe spontaneously through his tracheostomy 
tube. The tracheostomy tube was removed on day 33, and 
the next day the patient was transferred to the neurological 
department for further rehabilitation.
DISCUSSION
Despite the fact that tetanus has become a rare pathology 
in developed countries due to successful implementation 
of the primary immunization programme, the risk of its de-
velopment is still high because of low specific immunity in 
elderly people and persons not vaccinated due to religious 
or philosophical beliefs [6]. That is why some cases of teta-
nus are still registered in the United States of America. Eight 
cases of tetanus were registered in Canada during the 2008-
2013 period (7, 8), and 126 cases in England and Wales dur-
ing the 1984-1992 period (9).
In 2016, the WHO reported on 13,502 cases of tetanus in the 
world (against 10,377 in 2015), that were mainly connected 
with places of natural disasters such as earthquake, tsunami 
(Pakistan, Indonesia), and low-income countries, which do 
not have a complex immunization program (Somalia, Af-
ghanistan, Kenya) and the mortality of neonates and tod-
dlers is high (2, 10, 11).
Fifteen cases of tetanus in children were registered in 
Ukraine in 2011-2015, and six cases in 2016 (12). The statis-
tics is so sad and bad not only because of the interruption 
of vaccine provision, but also because of unwillingness of 
some parents to vaccinate their children.
According to the WHO definition, the main signs of tetanus 
are trismus (inability to open the mouth because of spasms 
in jaw muscles, risus sardonicus (progressive tonic spasm 
and contraction of mimic musculature with specific ‘smile 
mask’), and painful muscular cramps; history of injury or 
wound is required, although tetanus is also known to occur 
even when there is no recall of trauma (13).
There are several clinical forms of tetanus in children: gener-
alized, localized, cephalic and neonatal.
Generalized form occurs in 50%-75% of patients. Nuchal ri-
gidity and dysphagia are early signs, together with trismus 
and risus sardonicus (14). Total muscular rigidity with peri-
odical reflex contractions in response to minimal irritation 
develops in dynamics. Tonic contractions of muscles pro-
voke opisthotonus. Patients feel severe pain during these 
episodes. Spasm may lead to fractures and tendon ruptures. 
Other symptoms include hyperthermia, hypersalivation, ex-
cessive sweating, fever, irritability, dyspnea and asphyxia, ar-
rhythmia and cardiac arrest, uncontrolled urination or def-
ecation. The mortality rate in the case of generalized teta-
nus can be as high as 70%.
Patients with localized form of tetanus usually have persis-
tent contraction of muscles near the site of trauma. Mortal-
ity is very low in these cases (15).
Cephalic form occurs usually after head trauma or otitis me-
dia and manifests with cerebral nerve palsy, which is usually 
combined with the signs of generalized form.
Neonatal tetanus is a generalized form of the disease that 
develops in newborns, usually those born to mothers who 
themselves have not been vaccinated. It usually occurs 
through infection of the unhealed umbilical stump or ves-
sels, particularly when the stump is cut off with a non-sterile 
instrument. This form is the most lethal one; the mortality 
rate is near 90%. Thanks to global immunization efforts, an 
estimated 85% of newborns were protected through im-
munization in 2017, but maternal and neonatal tetanus still 
persists as a public health problem in 14 countries, mainly in 
Africa and Asia (1).
The first signs of tetanus develop three days to three weeks 
after the infection penetration, when trismus, risus sardoni-
cus, nuchal rigidity and dysphagia appear. Generalized tonic 
and clonic convulsions appear in 1-4 days.
Untimely diagnosis of the first signs of tetanus leads to 
breathing impairment, vegetative dysfunction that may 
end lethally. So, patients with clinically suspected tetanus 
should be hospitalized in a specialized ICU and should re-
ceive a multicomponent therapy, which includes primary 
surgical care, specific therapy with tetanus immunoglobu-
lin (tetanus antitoxin), antibacterial, anticonvulsive and 
symptomatic therapy.
This discussion needs to address several important issues.
Firstly, this presentation underlines the necessity of planned 
immunization, which is a unique method to prevent teta-
nus, a life-threatening disease that leads to disability and 
may develop at any skin or mucosal trauma, if contaminat-
ed with Clostridium tetani spores that are singularly stable in 
the external environment. Poor immunization coverage in 
Ukraine is a big problem. Even the availability of sufficient 
amounts of DTP vaccine in the country during the last year 
could not solve this problem. The 2017 immunization cov-
erage was only 50% because of a generally negative atti-
tude and fears of parents. Despite the formation of vaccina-
tion support groups, the negative propaganda makes their 
efforts frequently unnoticed.
Secondly, because the prodromal period of clinical tetanus 
is usually mimicking an ENT disorder (dysphagia, trismus, 
and neck pain), it is important that various medical special-
ists maintain a high level of suspicion and readiness to get 
involved in the multidisciplinary management of the dis-
ease.
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Thirdly, this clinical case teaches us to solve another impor-
tant problem, i.e. modern treatment of tetanus and main 
principles of its management (13, 16).
Current WHO recommendations include specific therapy 
with intramuscular tetanus immunoglobulin as soon as 
possible (10). For tetanus prophylaxis during wound man-
agement, a dosage of 250-500 IU is recommended for chil-
dren older than 7 years; in adults, an additional age-adjust-
ed tetanus toxoid containing vaccine, 0.5 cc, is administered 
by intramuscular injection at another site. For tetanus treat-
ment, 3,000 to 6,000 IU intramuscularly as a single dose is 
administered within the first 24 hours of diagnosis; thus, a 
total dose of 500 units is now recommended by many au-
thorities (17). For antibacterial therapy, metronidazole is 
preferred (30 mg/kg/day, administered every six hours in-
travenously or by mouth) and penicillin G (100,000-200,000 
IU/kg/day intravenously in 2-4 divided doses). Tetracyclines, 
macrolides, clindamycin, cephalosporins and chloram-
phenicol are also effective. The optimal management of 
tonic seizures in case of generalized tetanus requires venti-
lator support in the ICU plus one or more of the following: 
continuous infusion of midazolam, diazepam in a large 
dose (0.1-0.2 mg/kg/dose) every 2-6 hours, titrated upward 
as needed, propofol as a drug to potentiate sedation, and 
muscle relaxants are recommended (18,19). Baclofen, dan-
trolene (1-2 mg/kg/every 4 hours), vecuronium (0.1 mg/
kg/h), barbiturates (short acting, in continuous i.v. infusion, 
6-10 mg/kg/dose), and chlorpromazine (4-12 mg every 4-8 
hours) are recommended among other medicines (20,21). 
Magnesium sulphate is used both for muscular spasm con-
trol and for autonomic dysfunction management, 75 mg/
kg intravenous loading dose, then 2-3 grams per hour until 
spasm control is achieved (22). Morphine (1-2 mg/kg/every 
12 hours) is used successfully for pain control and autonom-
ic hyperreactivity control (21).
Rapid muscular mass loss develops in this group of patients 
because of excessive sympathetic activity and protein ca-
tabolism. A combination of parenteral and enteral feeding 
to restore metabolic losses is very important too (21).
CONCLUSION
Immunization is the single effective method to prevent 
tetanus; post-exposure prophylaxis could prevent general-
ized tetanus in those that were not immunized completely, 
or were immunized more than five years before. Early diag-
nosis of generalized tetanus in children remains a problem 
because of mimicking other disorders. Our clinical experi-
ence in the treatment of generalized tetanus in preschool-
ers according to modern European guidelines showed ef-
fectiveness of such treatment.
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S A Ž E T A K
Tetanus u djeteta kao rezultat nepoštivanja  
kalendara cijepljenja – prikaz slučaja
Halyna Pavlyshyn, Ivanna Horishna, Viktoriia Slyva
Analiziran je klinički slučaj generaliziranog tetanusa u predškolskog djeteta kod kojega se nije poštivao kalendar cijepljenja. Opisani 
su klinički znakovi teškog generaliziranog tetanusa. Prikazani su suvremeni pristupi liječenju ovakovih bolesnika, učinkovitost i oče-
kivana dobrobit terapije.
Ključne riječi: TETANUS; DJECA; LIJEČENJE
